Effect of Option Exercise. If, within the Option Period, Xxxxxxx or its designated Affiliate notifies Poseida in writing that it wishes to exercise the applicable Option, then Poseida and Xxxxxxx will commence good-faith negotiations to agree on reasonable, commercial terms for a royalty-bearing license associated with the Centyrin CAR Molecule(s) and/or Centyrin Therapeutic Molecule(s) with respect to such Option, provided that, inclusion of any Third Party intellectual property Controlled by Poseida within the applicable Poseida CAR Molecule Technology and/or Poseida Therapeutic Molecule Technology would be subject to Xxxxxxx assuming all payments (or prorata portion) to such Third Party that are applicable to such license. The Parties agree to negotiate in good faith for a period of […***…] days, which term can be extended by written agreement of the Parties (“Option Negotiation Period”). In the event, the Parties are unable to come to terms during the Option Negotiation Period, the Parties may terminate negotiations regarding such license and Poseida shall have no further obligations and Xxxxxxx shall have no further rights with respect to such Option. ***Certain Confidential Information Omitted CONFIDENTIAL - Xxxxxxx Biotech Inc. & Poseida Therapeutics Inc. License Agreement – August 3, 2015
Effect of Option Exercise. Upon the exercise of the Option by Seller with respect to the Option Assets, any Option Purchased Interests, Option Purchased Entities, Option Underlying Properties and/or Option Properties shall constitute Purchased Interests, Purchased Entities, Underlying Properties and Properties, respectively, hereunder, and this Agreement will be deemed amended, without any further action on the part of any Party, with respect to the Option Assets as follows:
Effect of Option Exercise. Within [***] days after PharmaMar’s exercise of its Co-Promotion Option, pursuant to Section 7.9(a), the Parties will execute a joint commercial agreement that sets forth the terms and conditions pursuant to which the Parties will collaborate in promoting the Licensed Products in the Licensed Indications in the Jazz U.S. Territory, including the terms set forth on Exhibit F (the “Co-Promotion Agreement”).
Effect of Option Exercise. With respect to the Optioned Products, subject to the other terms and conditions of this Agreement, and effective upon receipt by NexMed of payment pursuant to Section 8.2.2 with respect to the Optioned Products:
Effect of Option Exercise. 4.6.1 Upon delivery of the Option Notice to Arrowhead, the Parties will cooperate to ensure orderly transition of the Program to Xxxxxxx to provide uninterrupted development of the applicable Licensed Construct or Licensed Product. Arrowhead will make available to Xxxxxxx, at Xxxxxxx’x reasonable request, any material information related to the Program. Notwithstanding any term of this Agreement to the contrary, Arrowhead shall not be obligated to disclose to Xxxxxxx its trade secrets. including information from which such trade secrets are likely to be elucidated, related solely to trigger selection or construct design.
Effect of Option Exercise. 31 18.05 Obligations of Lessee Upon Option Exercise....... 31 18.06 Obligations of HCG............................... 31 18.07
Effect of Option Exercise. Immediately upon HCG's notice to ------------------------- Lessee of HCG' s exercise of the Option, as set forth in Section 18.03, above, Lessee's right to use Lessee's Reserve Transponder(s) shall automatically and without further action on Lessee's or HCG's part cease.
Effect of Option Exercise. (a) Statement of Reimbursable Costs; Other Information. Within [***] days of RSL’s receipt of the Exercise Notice, RSL will provide (or will cause the applicable Covered Affiliate to provide) Myovant with (i) a statement of all Reimbursable Costs incurred to date under the RSL Collaboration Agreement, and all further Reimbursable Costs reasonably anticipated by RSL or such Covered Affiliate to be incurred within the next [***] days, together with any supporting documentation reasonably requested by Myovant, (ii) a summary of current development and commercialization programs contemplated by Myovant with respect to the any Option Product, including a good faith estimate of the Reimbursable Costs that would be incurred by RSL during the next calendar year if such RSL Collaboration is not assigned to Myovant and (iii) to the extent that any documents or information described in Section 3.5(a) or (b) exists but has not yet been provided to Myovant, such documents and information.
Effect of Option Exercise. 15 3.5 Transfer of Sale Obligation to the Company . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Effect of Option Exercise. Each purchase of Option Units will be effective as of the July 1 immediately preceding the Option Date on which the Option is exercised with regard to those Option Units and the Buyer will be entitled to all earnings, gains, losses and other financial incidents allocable to those Option Units as though they had been issued on that July 1.
